[The 1996 revision of the Dutch cervical cancer screening programme: increased coverage, fewer repeat smears and less opportunistic screening]
- PMID: 17624160
[The 1996 revision of the Dutch cervical cancer screening programme: increased coverage, fewer repeat smears and less opportunistic screening]
Abstract
Objective: Comparison of the indicators of effectiveness and efficiency of the Dutch national cervical cancerscreening programme in 2003 and 1994, the last year before implementation of important changes in the medical and organisational guidelines.
Design: Descriptive.
Method: Data on all Pap smears made in 1994 and 2003 were retrieved from the Pathologic Anatomical National Automated Archive (PALGA), together with the matching cytological and histological follow-up until April 2004. In order to calculate the 5-year coverage, the number of women that had had a smear taken was placed in the numerator and divided by the number of women that had been invited for the screening programme during those 5 years.
Results: The 5-year coverage in the age range 30-64 years increased from 69 in 1994 to 77% in 2003. The percentage of smears resulting in a recommendation for a repeat smear decreased from 10 to 2. The percentage of timely compliance with recommendations for a repeat smear increased from 47 to 86, while that of smears with an immediate referral recommendation remained the same (about go). There was a sharp decrease in screening outside of the target-age range and screening with too short an interval. As a consequence, despite the higher coverage, the total number of smears decreased.
Conclusion: The changes in the Dutch cervical cancerscreening programme in 1996 with regard to participation, the number of and compliance with recommendations for repeat smears, and screening activity outside of the target group were accompanied by significant improvements in agreement with the goals of the revision. The potential consequences for the effectiveness of the screening programme (reduction of cervical cancer mortality) will become apparent in the years to come.
Comment in
-
[On the occasion of the 65th birthday of the cervical smear: added value of population studies for cervical cancer remains unclear].Ned Tijdschr Geneeskd. 2007 Jun 9;151(23):1268-71. Ned Tijdschr Geneeskd. 2007. PMID: 17624154 Dutch.
Similar articles
-
[Less pap-2 results ('minor abnormalities') in the population screening for cervical cancer since the introduction of new guidelines in 1996].Ned Tijdschr Geneeskd. 2002 Aug 24;146(34):1586-90. Ned Tijdschr Geneeskd. 2002. PMID: 12224483 Dutch.
-
Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.BMC Health Serv Res. 2007 Jan 23;7:10. doi: 10.1186/1472-6963-7-10. BMC Health Serv Res. 2007. PMID: 17244348 Free PMC article.
-
[Follow up after an abnormal pap smear: time interval acceptable, nature of follow up leaves room for improvement].Ned Tijdschr Geneeskd. 2003 Dec 6;147(49):2430-4. Ned Tijdschr Geneeskd. 2003. PMID: 14694554 Dutch.
-
[Population screening for uterine cervix cancer: the negative effects of insufficient knowledge as to what is normal and abnormal].Ned Tijdschr Geneeskd. 2002 Aug 24;146(34):1569-71. Ned Tijdschr Geneeskd. 2002. PMID: 12224477 Review. Dutch.
-
[The Pap test revisited].Minerva Ginecol. 1991 Mar;43(3):71-85. Minerva Ginecol. 1991. PMID: 2057106 Review. Italian.